FAS and osteosarcoma: Interestingly, treatment with cisplatin could not upregulate the cell-surface Fas antigen but it did sensitize human osteosarcoma cells to Fas-mediated apoptosis by down-regulating the expression of FLICE inhibitory protein long form (FLIP-L).